Through this collaboration, a new telemedicine system will be established by combining AMI's AI-equipped digital stethoscope "Super Stethoscope* (telemedicine support system "Cloud Super Diagnosis®")" and MUSVI's telepresence system "Window" to enable remote listening and cardiac screening by specialists in urban areas even in remote islands and remote areas where there are no specialists available. This new telemedicine system will enable remote audiology and screening for cardiac disease by specialists in urban areas, even in areas where there are no specialists, such as remote islands and remote areas.


Background and Issues
As Japan's population ages, the number of patients with cardiac diseases such as heart failure and valvular heart disease is increasing. On the other hand, there is a growing shortage of cardiologists in rural areas, remote islands, and remote regions, making it difficult to provide appropriate initial diagnosis and prompt screening. As a result, the detection of diseases is delayed, increasing the risk of serious illness and emergency transport, which is a major challenge.
Why is a medical interview and auscultation necessary?
In cardiac disease, changes in heart sounds may appear from the earliest stages of the disease. Skilled auscultation and careful interviewing may detect early the need for lifestyle modification and ambiguous early signs of heart failure and valvular disease.
Furthermore, the results of past efforts are showing that in online medical care, the ability to "interview" and "listen" with clear acoustics, which is comparable to face-to-face, is very important as a base requirement.
In the case of "Q&A," it is difficult to express voice in the same way as in real life using general videoconferencing tools. Specifically, even if the patient's image is projected in front of them, if the timing of the patient's voice is the same as that of the other person's voice when they speak, it causes a great deal of stress for the user, such as the communication of "please repeat that". In addition, it is difficult for doctors to hear the patient's pain and worries.
In this respect, the "interview" with the "window" realizes a natural feeling as if the patient is having a real conversation with the doctor, and for the doctor, a feeling of "being there" and a clear understanding of the patient's voice and facial expression.
Auscultation is an important method of medical examination that is painless and reassuring for patients to have their physical condition carefully checked, and useful for medical professionals to detect abnormal heart and lung sounds at an early stage and determine a diagnosis and treatment plan. It is non-invasive, quick, and can deepen confidence in health care by promptly providing appropriate responses.
solution (esp. to a problem)
The system under this collaboration will realize remote medical care through the following mechanisms
1. medical personnel in the field (remote islands and remote areas) acquire heart sounds and electrocardiographic data with a "super stethoscope" and connect to the "window" through a PC.
2. physicians in urban areas can check the data acquired by the super stethoscope in real time via the content sharing function while interviewing the patient in the "window," which allows for communication equivalent to face-to-face meetings. Instructions for reacquisition can also be given remotely if necessary.
3. acquired data is automatically uploaded to the cloud super diagnostics, and the AI analysis results can be referenced in about 1 to 2 minutes.
4. the physician decides whether or not the patient needs to come to the hospital and whether or not to follow up, based on the analysis results and voice data.
Through this, we aim to create a new telemedicine model in which medical professionals in the field and specialists in urban areas can collaborate to determine cardiac disease risk "on the spot.
Expected Effects
Provides specialist-level screening for cardiac disease in areas where there are no specialists available.
Prevention of serious illness and reduction of medical costs by speeding up initial diagnosis
Reduction of patient burden (reduction of unnecessary long-distance travel and transport)
Correction of medical disparities and promotion of community-based comprehensive care
Future Outlook
Starting with this collaboration, the two companies will promote the deployment of the system not only to remote islands and remote areas, but also to a wide range of sites, including nursing care facilities and home healthcare. Furthermore, with an eye on international expansion, the two companies will contribute to eliminating disparities in access to medical care around the world.
Comment from Mr. Yusuke Sakai, President, Founder & CEO, MUSVI Corporation
By combining "Window," which enables realistic interaction with doctors and medical staff even when they are far away, and AMI's "Super Stethoscope," which aims to assist in rapid and wide-ranging diagnosis from patient heartbeat and electrocardiogram data using AI and other technologies, we will contribute to solving medical issues in remote islands and mountainous areas.
Comments from Mr. Shinpei Ogawa, Representative Director and CEO, AMI, Inc.
This collaboration with MUSVI is a major first step toward the early detection of heart disease and the elimination of regional healthcare disparities. Our goal is to realize a society in which everyone has access to quality medical care wherever they are.
Using this initiative as a starting point, AMI will further advance AI and cloud technologies to take on the challenge of creating a system to deliver medical care to places of daily life such as home healthcare and nursing homes. In the future, we would like to expand our business overseas, where the issue of access to medical care is more serious, and build a system of medical care that provides peace of mind around the world.
AMI is committed to revolutionizing the "accepted practice of medicine" and realizing a sustainable and equitable healthcare infrastructure through the development of innovative medical devices and the implementation of telemedicine services in society.
MUSVI Corporation|Company Profile
| name of company | MUSVI Corporation |
| Establishment | January 2022 |
| Location | 5-5-15, Kitashinagawa, Shinagawa-ku, Tokyo |
| representative | Representative Director / Founder & CEO Yusuke Sakai |
| Business Overview | 1. Development, planning and operation of the real-space connection platform "MUSVI 2. Sales, leasing and consulting of telepresence system "windows 3.Research and development of telepresence technology and provision of related solutions |
| uniform resouce locator | HP:https://musvi.jp/ Release:https://musvi.jp/2025/09/30/4925/ |
AMI Corporation|Company Profile
AMI is an R&D startup from Kyushu, Japan, which is working on "Audiology DX*" through research and development of "Super Stethoscope (telemedicine-compatible stethoscope with cardiac disease diagnosis assist function)". Through product development utilizing acoustic engineering, electronics, and AI technologies, and social implementation of telemedicine services, AMI aims to realize a world in which anyone can receive high-quality medical care anywhere.
We not only digitize auscultation, but also provide new value to the medical field by utilizing it for medical practice, clinical research, medical education, and telemedicine.
This is a promotional video for AMI. Please take a look.
AMI Corporation|Company Profile
| name of company | AMI Corporation |
| Establishment | November 2015 |
| Location | Head Office: 302, 2-13 Higashi Sengoku-cho, Kagoshima City, Kagoshima Prefecture, Japan Head Office: 5-98 Hamamatsu-cho, Minamata City, Kumamoto Prefecture |
| representative | Shinpei Ogawa, Representative Director and CEO |
| Business Overview | Development of medical equipment and provision of telemedicine services |
| uniform resouce locator | https://ami.inc/ Contact us for a demo or rental:https://ami.inc/products-service *Healthcare professionals only |









